Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a brief home therapy cut suicide reattempts? new study aims to find out

NCT ID NCT06322199

Disease control Sponsor: University of Bern Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a short, home-based therapy called ASSIP Flex for adults who have attempted suicide. The therapy involves 3-4 sessions delivered in the patient's own environment. Researchers will track suicidal thoughts and behaviors over 12 months to see if the therapy is feasible, cost-effective, and helps reduce repeat attempts. The study enrolls 119 participants in Switzerland.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ASSIP Flex (a brief, home-based behavioral therapy for people who have attempted suicide)
What this could lead to
If it works, this could provide an effective, cost-saving way to deliver suicide prevention therapy at home, reducing repeat attempts.
What could go wrong
This is a small feasibility study (119 people) with no control group, so results may not prove effectiveness. The therapy may not work for everyone, and some participants might drop out.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

119 people

The number who actually took part.

Started

Sep 2022

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants with a past suicide attempt will be recruited at the University Hospital of Psychiatry and Psychotherapy Bern (Switzerland) and following recruitment centers: * Sanatorium Kilchberg Private Clinic for Psychiatry and Psychotherapy * Psychiatric University Hospital Zurich (PUKZH) * Vaud University Hospital (CHUV) in Lausanne * Department of General and Liaison Psychiatry CNP in Neuchâtel

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Subjects fulfilling the following inclusion criteria are eligible for the study: * Informed consent as documented by signature * Age ≥ 18 years * At least one previous suicide attempt * Willingness to attend the ASSIP Flex Exclusion Criteria: The presence of any one of the following exclusion criteria will lead to exclusion of the subject: * Serious cognitive impairment * Any psychotic disorder * Inability to follow the procedures of the study (e.g., insufficient mastery of the German language, previous enrolment into the current study)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cost-effectiveness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Suicidal Ideation Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cost-effectiveness Feasibility Process factors Suicidal ideation Suicide, attempted

Contacts and locations

Locations

  • Center Neuchâtelois de Psychiatrie

    Neuchâtel, Switzerland

  • Centre Hospitalier universitaire vaudois (CHUV)

    Lausanne, Switzerland

  • Psychiatric Hospital, University of Zurich (PUKZH)

    Zurich, Switzerland

  • Sanatorium Kilchberg

    Zurich, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.